NASDAQ:MBOT - Microbot Medical Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $7.94 +0.04 (+0.51 %) (As of 03/26/2019 12:31 PM ET)Previous Close$7.90Today's Range$7.94 - $7.9452-Week Range$1.38 - $19.40Volume100 shsAverage Volume183,827 shsMarket Capitalization$34.22 millionP/E RatioN/ADividend YieldN/ABeta5.51 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures. It also holds an intellectual property portfolio that comprises 9 patent families, which include 9 patents granted in the United States, 12 patents granted outside the United States, and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts. Receive MBOT News and Ratings via Email Sign-up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:MBOT Previous Symbol CUSIPN/A CIK883975 Webwww.microbotmedical.com Phone781-875-3605Debt Debt-to-Equity RatioN/A Current Ratio12.44 Quick Ratio12.44Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$4.06 per share Price / Book1.96Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-7,580,000.00 Net MarginsN/A Return on Equity-77.99% Return on Assets-73.30%Miscellaneous EmployeesN/A Outstanding Shares4,310,000Market Cap$34.22 million Next Earnings Date3/27/2019 (Estimated) OptionableNot Optionable Microbot Medical (NASDAQ:MBOT) Frequently Asked Questions What is Microbot Medical's stock symbol? Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT." When did Microbot Medical's stock split? How did Microbot Medical's stock split work? Microbot Medical's stock reverse split on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of Microbot Medical stock prior to the reverse split would have 8 shares after the split. How were Microbot Medical's earnings last quarter? Microbot Medical Inc (NASDAQ:MBOT) released its quarterly earnings results on Wednesday, November, 14th. The biotechnology company reported ($0.58) earnings per share for the quarter, beating analysts' consensus estimates of ($0.60) by $0.02. View Microbot Medical's Earnings History. When is Microbot Medical's next earnings date? Microbot Medical is scheduled to release their next quarterly earnings announcement on Wednesday, March 27th 2019. View Earnings Estimates for Microbot Medical. What price target have analysts set for MBOT? 1 brokerages have issued 12 month price targets for Microbot Medical's stock. Their forecasts range from $1.75 to $1.75. On average, they expect Microbot Medical's share price to reach $1.75 in the next year. This suggests that the stock has a possible downside of 78.0%. View Analyst Price Targets for Microbot Medical. What is the consensus analysts' recommendation for Microbot Medical? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbot Medical in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Microbot Medical. Has Microbot Medical been receiving favorable news coverage? News articles about MBOT stock have been trending somewhat negative on Tuesday, InfoTrie Sentiment reports. The research firm identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Microbot Medical earned a news impact score of -1.4 on InfoTrie's scale. They also gave headlines about the biotechnology company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near future. Are investors shorting Microbot Medical? Microbot Medical saw a drop in short interest in February. As of February 28th, there was short interest totalling 381,268 shares, a drop of 33.4% from the February 15th total of 572,718 shares. Based on an average daily volume of 236,612 shares, the days-to-cover ratio is currently 1.6 days. Currently, 12.1% of the company's stock are sold short. View Microbot Medical's Current Options Chain. Who are some of Microbot Medical's key competitors? Some companies that are related to Microbot Medical include Nantkwest (NK), Organovo (ONVO), AVITA MED LTD/S (AVMXY), Surface Oncology (SURF), Champions Oncology (CSBR), Pluristem Therapeutics (PSTI), Fennec Pharmaceuticals (FENC), Outlook Therapeutics (OTLK), Aptose Biosciences (APTO), Brainstorm Cell Therapeutics (BCLI), INmune Bio (INMB), Applied Genetic Technologies (AGTC), Genocea Biosciences (GNCA), Idera Pharmaceuticals (IDRA) and Cidara Therapeutics (CDTX). What other stocks do shareholders of Microbot Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Microbot Medical investors own include TransEnterix (TRXC), Novavax (NVAX), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Athersys (ATHX), Sarepta Therapeutics (SRPT), Cara Therapeutics (CARA), Conatus Pharmaceuticals (CNAT), GW Pharmaceuticals PLC- (GWPH) and Inovio Pharmaceuticals (INO). Who are Microbot Medical's key executives? Microbot Medical's management team includes the folowing people: Mr. Harel Gadot, Co-Founder, Pres, CEO & Chairman (Age 46)Mr. Yoseph Bornstein, Co-Founder & Director (Age 60)Mr. David Ben Naim CPA, M.B.A., Chief Financial Officer (Age 50)Dr. Simon Sharon, Chief Technology OfficerProf. Moshe Shoham, Co-Founder, Scientific Director & Member of Scientific Advisory Board (Age 67) Who are Microbot Medical's major shareholders? Microbot Medical's stock is owned by a number of of institutional and retail investors. Top institutional investors include Geode Capital Management LLC (0.51%) and Geode Capital Management LLC (0.51%). Company insiders that own Microbot Medical stock include Alliance Investment Management, Leon Lewkowicz, Moshe Shoham, Yoav Zvi Waizer and Yoseph Bornstein. View Institutional Ownership Trends for Microbot Medical. Which institutional investors are buying Microbot Medical stock? MBOT stock was bought by a variety of institutional investors in the last quarter, including Geode Capital Management LLC and Geode Capital Management LLC. Company insiders that have bought Microbot Medical stock in the last two years include Alliance Investment Management and Yoav Zvi Waizer. View Insider Buying and Selling for Microbot Medical. How do I buy shares of Microbot Medical? Shares of MBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Microbot Medical's stock price today? One share of MBOT stock can currently be purchased for approximately $7.94. How big of a company is Microbot Medical? Microbot Medical has a market capitalization of $34.22 million. What is Microbot Medical's official website? The official website for Microbot Medical is http://www.microbotmedical.com. How can I contact Microbot Medical? Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The biotechnology company can be reached via phone at 781-875-3605 or via email at [email protected] MarketBeat Community Rating for Microbot Medical (NASDAQ MBOT)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 262 (Vote Outperform)Underperform Votes: 194 (Vote Underperform)Total Votes: 456MarketBeat's community ratings are surveys of what our community members think about Microbot Medical and other stocks. Vote "Outperform" if you believe MBOT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MBOT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/26/2019 by MarketBeat.com StaffFeatured Article: Why is the ROA ratio important?